<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00517127</url>
  </required_header>
  <id_info>
    <org_study_id>431/2005</org_study_id>
    <nct_id>NCT00517127</nct_id>
  </id_info>
  <brief_title>Crystalloids Versus Colloids During Surgery</brief_title>
  <acronym>CC</acronym>
  <official_title>A Comparison of Crystalloids vs. Colloids for Intraoperative Goal-directed Fluid Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to test whether colloid-based goal-directed intraoperative fluid&#xD;
      management leads to less perioperative morbidity compared to crystalloid-based goal-directed&#xD;
      intraoperative fluid management. Goal-directed therapy is based on measurements by an&#xD;
      Esophageal Doppler Device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For a long time there is a raging debate whether crystalloid solutions or colloid solutions&#xD;
      are better suited for fluid therapy. Early proponents both for crystalloids [Shires 1961] and&#xD;
      colloids [Shoemaker 1979] deserve credit for elucidating important facts about volume&#xD;
      replacement therapy - without answering the primary question. Elaborate reviews comparing&#xD;
      crystalloid and colloid therapy for critically ill patients have been performed in the late&#xD;
      nineties and updated recently [Roberts 2004]. However, it has been suggested that both&#xD;
      questions and answers of reviews leave us none but wiser [Webb 1999]. Although a plethora of&#xD;
      studies comparing crystalloid vs. colloid therapy in the last decades have been published,&#xD;
      volume replacement therapy is still considered to be based on dogma and personal beliefs&#xD;
      [Boldt 2003].&#xD;
&#xD;
      Goal-directed intraoperative fluid therapy monitored by Esophageal Doppler identifies&#xD;
      volume-responders, thereby decreasing length of stay in hospital in orthopedic [Sinclair&#xD;
      1997], cardiac [Mythen 1995], and abdominal surgery patients [Gan 2002, Wakeling 2005,&#xD;
      Noblett 2006]. However, all these studies have been performed with a colloid to be the&#xD;
      substance applied. Thus, it has been questioned whether monitoring with the Esophageal&#xD;
      Doppler monitor, or the application of additional colloid improved outcome [Horowitz, Kumar&#xD;
      2003].&#xD;
&#xD;
      Consequently, the researchers will use Esophageal Doppler Monitoring for intraoperative&#xD;
      goal-directed fluid therapy to compare the effects of crystalloid vs. colloid therapy on&#xD;
      various organ systems, assessing combined perioperative morbidity [Bennett-Guerrero 1999] .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>combined perioperative morbidity</measure>
    <time_frame>30 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tissue oxygenation, Wound Infection, Incidence of postoperative nausea and vomiting (PONV) and pain, pulmonary function,</measure>
    <time_frame>30 days after surgery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Coagulation (ROTEM)</measure>
    <time_frame>intraop, postop day1</time_frame>
    <description>in a subgroup of 50 patients undergoing hepatic resection ROTEM measurements will be performed intraoperatively, postoperatively and on the first postoperative morning and compared between the groups.</description>
  </other_outcome>
  <other_outcome>
    <measure>Inflammatory response attenuation by HES 130/0.4</measure>
    <time_frame>4 postoperative days</time_frame>
    <description>In a subgroups of 120 patients the postoperative immune function will be evaluated and compared between crystalloids and colloids.&#xD;
The immunological parameters include:&#xD;
IL6, IL-8, IL-10, Procalcitonin, lipopolysaccharide-binding protein, HLA-DR Expression, CRP C-reactive protein, leucocytes, TNF alpha Blood samples will be collected immediately before surgery (T0) for baseline measurement, immediately after surgery finish (T1), and on postoperative day one, two and four (T2, T3 and T4).</description>
  </other_outcome>
  <other_outcome>
    <measure>Body Composition Monitor Measurement (BCM)</measure>
    <time_frame>pre and postoperatively</time_frame>
    <description>In a subgroup of 100 patients overhydration will be evaluated pre- and immediately postoperatively with a body composition monitor (BCM), a whole-body bioimpedance spectroscopy device manufactured and distributed by Fresenius Medical Care, Germany.&#xD;
Measurements will be compared betwwen the groups</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1109</enrollment>
  <condition>Fluid Overload</condition>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm Nr 1: If corrected flow time (fTc), measured by esophageal doppler, falls below 350 msec, 250 ml of Lactated Ringer's Solution will be administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm Nr 2: If corrected flow time (fTc), measured by esophageal doppler, falls below 350 msec, 250 ml of Hydroxyethylstarch 6% 130/0.4 will be administered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactated Ringer's Solution</intervention_name>
    <description>Arm Nr 1: If corrected flow time (fTc), measured by esophageal doppler, falls below 350 msec, 250 ml of Lactated Ringer's Solution will be administered.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxyethylstarch 6% 130/0.4</intervention_name>
    <description>Arm Nr 2: If corrected flow time (fTc), measured by esophageal doppler, falls below 350 msec, 250 ml of Hydroxyethylstarch 6% 130/0.4 will be administered.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  After written informed consent patients undergoing elective open colon surgery, or&#xD;
             open hysterectomy or myomectomy, or spine surgery or hip replacement will be included&#xD;
             in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients having severe cardiac or renal insufficiency&#xD;
&#xD;
          -  Patients with severe coronary artery disease&#xD;
&#xD;
          -  Patients with insulin-dependent diabetes mellitus&#xD;
&#xD;
          -  Patients with severe COPD&#xD;
&#xD;
          -  Patients with symptoms of infections or sepsis&#xD;
&#xD;
          -  Patients with allergy to hydroxyethylstarch.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edith Fleischmann, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, University of Vienna Medical School, Vienna, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <removed_countries>
    <country>Switzerland</country>
  </removed_countries>
  <reference>
    <citation>SHIRES T, WILLIAMS J, BROWN F. Acute change in extracellular fluids associated with major surgical procedures. Ann Surg. 1961 Nov;154:803-10.</citation>
    <PMID>13912109</PMID>
  </reference>
  <reference>
    <citation>Shoemaker WC, Hauser CJ. Critique of crystalloid versus colloid therapy in shock and shock lung. Crit Care Med. 1979 Mar;7(3):117-24.</citation>
    <PMID>436427</PMID>
  </reference>
  <reference>
    <citation>Roberts I, Alderson P, Bunn F, Chinnock P, Ker K, Schierhout G. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000567. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD000567.</citation>
    <PMID>15495001</PMID>
  </reference>
  <reference>
    <citation>Webb AR. Crystalloid or colloid for resuscitation. Are we any the wiser? Crit Care. 1999;3(3):R25-R28.</citation>
    <PMID>11094479</PMID>
  </reference>
  <reference>
    <citation>Boldt J. New light on intravascular volume replacement regimens: what did we learn from the past three years? Anesth Analg. 2003 Dec;97(6):1595-1604. doi: 10.1213/01.ANE.0000089961.15975.78. Review. Retraction in: Anesth Analg. 2020 Aug;131(2):e137.</citation>
    <PMID>14633526</PMID>
  </reference>
  <reference>
    <citation>Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: randomised controlled trial. BMJ. 1997 Oct 11;315(7113):909-12.</citation>
    <PMID>9361539</PMID>
  </reference>
  <reference>
    <citation>Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg. 1995 Apr;130(4):423-9.</citation>
    <PMID>7535996</PMID>
  </reference>
  <reference>
    <citation>Gan TJ, Soppitt A, Maroof M, el-Moalem H, Robertson KM, Moretti E, Dwane P, Glass PS. Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery. Anesthesiology. 2002 Oct;97(4):820-6.</citation>
    <PMID>12357146</PMID>
  </reference>
  <reference>
    <citation>Wakeling HG, McFall MR, Jenkins CS, Woods WG, Miles WF, Barclay GR, Fleming SC. Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005 Nov;95(5):634-42. Epub 2005 Sep 9.</citation>
    <PMID>16155038</PMID>
  </reference>
  <reference>
    <citation>Noblett SE, Snowden CP, Shenton BK, Horgan AF. Randomized clinical trial assessing the effect of Doppler-optimized fluid management on outcome after elective colorectal resection. Br J Surg. 2006 Sep;93(9):1069-76.</citation>
    <PMID>16888706</PMID>
  </reference>
  <reference>
    <citation>Horowitz PE, Kumar A. It's the colloid, not the esophageal Doppler monitor. Anesthesiology. 2003 Jul;99(1):238-9; author reply 239.</citation>
    <PMID>12826872</PMID>
  </reference>
  <reference>
    <citation>Bennett-Guerrero E, Welsby I, Dunn TJ, Young LR, Wahl TA, Diers TL, Phillips-Bute BG, Newman MF, Mythen MG. The use of a postoperative morbidity survey to evaluate patients with prolonged hospitalization after routine, moderate-risk, elective surgery. Anesth Analg. 1999 Aug;89(2):514-9.</citation>
    <PMID>10439777</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>August 15, 2007</study_first_submitted>
  <study_first_submitted_qc>August 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2007</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Barbara Kabon</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Intraoperative care</keyword>
  <keyword>Ringer's lactate</keyword>
  <keyword>Voluven</keyword>
  <keyword>Cardiovascular diagnostic technique</keyword>
  <keyword>Doppler effect</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

